Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Oral formulations for anti-tumor compounds

US Patent 7201913 · Granted Apr 10, 2007

Estimated economic value: $406,668,000

Assignee

Inventors

View full patent text on Google Patents →